We are live on
!
Find out more
Vanguard Portfolio Management Portfolio holdings
AUM
$2.22T
This Fund
S&P 500
This Quarter
Est. Return
+25.71%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.22T
AUM Growth
+$305B
(+16%)
Cap. Flow
+$19.5B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
21.57%
Holding
3,286
New
192
Increased
2,077
Reduced
864
Closed
145
Avg Time Held
0.9
quarters
Top 10 Avg Time Held
0.8
quarters
Top 20 Avg Time Held
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$1.74B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$1.66B |
| 3 |
NVIDIA
NVDA
|
+$1.58B |
| 4 |
Micron Technology
MU
|
+$1.23B |
| 5 |
Devon Energy
DVN
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$2.45B |
| 2 |
Seagate
STX
|
+$2.36B |
| 3 |
Western Digital
WDC
|
+$1.98B |
| 4 |
Honeywell
HON
|
+$1.74B |
| 5 |
Corning
GLW
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Financials | 11.67% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 9.73% |
| 5 | Consumer Discretionary | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2951
Prelude Therapeutics
PRLD
$301M
| $1.03M | ﹤0.01% |
+193,920
| New | +$844K |
2026 Q2
0 quarters
|
|
2952
MediWound
MDWD
$164M
| $1.03M | ﹤0.01% |
70,143
+12,596
| +22% | +$200K |
2026 Q1
1 quarter
|
|
2953
Smart Sand
SND
$228M
| $1.02M | ﹤0.01% |
+204,507
| New | +$1.03M |
2026 Q2
0 quarters
|
|
|
CMDB
2954
Costamare Bulkers Holdings
CMDB
$520M
| $1.02M | ﹤0.01% |
58,059
+7,001
| +14% | +$122K |
2026 Q1
1 quarter
|
|
|
BRT
2955
BRT Apartments
BRT
$254M
| $1.02M | ﹤0.01% |
66,281
+3,767
| +6% | +$54.6K |
2026 Q1
1 quarter
|
|
2956
FreightCar America
RAIL
$204M
| $1.01M | ﹤0.01% |
+104,005
| New | +$876K |
2026 Q2
0 quarters
|
|
|
BRCB
2957
Black Rock Coffee Bar Inc
BRCB
$162M
| $1.01M | ﹤0.01% |
121,486
+21,261
| +21% | +$212K |
2026 Q1
1 quarter
|
|
|
WHWK
2958
Whitehawk Therapeutics
WHWK
$191M
| $1M | ﹤0.01% |
+219,217
| New | +$912K |
2026 Q2
0 quarters
|
|
2959
EverCommerce
EVCM
$1.64B
| $1M | ﹤0.01% |
99,628
+2,665
| +3% | +$28.2K |
2026 Q1
1 quarter
|
|
|
SPRB
2960
Spruce Biosciences
SPRB
$126M
| $999K | ﹤0.01% |
+18,496
| New | +$1.03M |
2026 Q2
0 quarters
|
|
2961
ECB Bancorp
ECBK
$182M
| $998K | ﹤0.01% |
49,702
+6,449
| +15% | +$119K |
2026 Q1
1 quarter
|
|
|
KGEI
2962
Kolibri Global Energy
KGEI
$233M
| $995K | ﹤0.01% |
199,763
+25,731
| +15% | +$137K |
2026 Q1
1 quarter
|
|
2963
Lifecore Biomedical
LFCR
$244M
| $993K | ﹤0.01% |
189,073
+24,513
| +15% | +$123K |
2026 Q1
1 quarter
|
|
2964
GrafTech
EAF
$221M
| $975K | ﹤0.01% |
165,025
+145,416
| +742% | +$1.23M |
2026 Q1
1 quarter
|
|
2965
Ampco-Pittsburgh
AP
$191M
| $975K | ﹤0.01% |
+112,721
| New | +$1.14M |
2026 Q2
0 quarters
|
|
2966
Commercial Vehicle Group
CVGI
$116M
| $971K | ﹤0.01% |
+210,102
| New | +$985K |
2026 Q2
0 quarters
|
|
2967
OptimizeRx
OPRX
$157M
| $970K | ﹤0.01% |
169,538
-161,499
| -49% | -$928K |
2026 Q1
1 quarter
|
|
2968
CAMP4 Therapeutics
CAMP
$236M
| $965K | ﹤0.01% |
+220,717
| New | +$952K |
2026 Q2
0 quarters
|
|
2969
CuriosityStream
CURI
$176M
| $964K | ﹤0.01% |
362,482
+39,737
| +12% | +$117K |
2026 Q1
1 quarter
|
|
2970
BV Financial
BVFL
$185M
| $964K | ﹤0.01% |
45,499
+5,665
| +14% | +$113K |
2026 Q1
1 quarter
|
|
2971
Information Services Group
III
$279M
| $963K | ﹤0.01% |
234,339
+27,903
| +14% | +$117K |
2026 Q1
1 quarter
|
|
2972
Amplify Energy
AMPY
$188M
| $960K | ﹤0.01% |
+241,286
| New | +$1.24M |
2026 Q2
0 quarters
|
|
2973
ADC Therapeutics
ADCT
$194M
| $960K | ﹤0.01% |
897,092
-136,185
| -13% | -$397K |
2026 Q1
1 quarter
|
|
2974
Westwood Holdings Group
WHG
$184M
| $958K | ﹤0.01% |
50,013
+7,147
| +17% | +$120K |
2026 Q1
1 quarter
|
|
|
XZO
2975
Exzeo Group
XZO
$1.36B
| $958K | ﹤0.01% |
56,768
+11,533
| +25% | +$170K |
2026 Q1
1 quarter
|
|
Similar funds
Vanguard Portfolio Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Portfolio Management held 3,286 positions worth $2.22T, up 16% from $1.91T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Vanguard Portfolio Management's Q2 2026 filing shows 192 new, 2,077 increased, 864 reduced and 145 closed positions. Its largest new stake was SpaceX: 10,225,389 shares worth $1.75B. The largest sale was Marvell Technology, an estimated $2.45B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.
- Vanguard Portfolio Management's largest Q2 2026 buy was SpaceX: 10,225,389 shares worth $1.75B.
- Vanguard Portfolio Management added most to NVIDIA in Q2 2026, an estimated $1.58B increase.
- Vanguard Portfolio Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $2.45B.
- Vanguard Portfolio Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.3B.
- Vanguard Portfolio Management's ten largest holdings make up 22% of its $2.22T portfolio in Q2 2026.
- Vanguard Portfolio Management opened 192 new positions and closed 145 in Q2 2026.
- Vanguard Portfolio Management's portfolio value rose 16% quarter-over-quarter to $2.22T.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.